Use of a metabolic inhibitor to reduce dapsone-dependent haematological toxicity
- 1 January 1992
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 25 (1), 1-16
- https://doi.org/10.1002/ddr.430250102
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- An Investigation into the Haematological Toxicity of Structural Analogues of Dapsone In-vivo and In-vitroJournal of Pharmacy and Pharmacology, 1991
- Gonadal Influence on the Metabolism and Haematological Toxicity of Dapsone in the RatJournal of Pharmacy and Pharmacology, 1990
- The active site of cytochrome P-450 nifedipine oxidase: a model-building studyJournal of Molecular Graphics, 1989
- Evidence for two closely related isozymes of arylamine N‐acetyltransferase in human liverFEBS Letters, 1989
- Aerobic nitroreduction of dehydrochloramphenicol by bone marrowToxicology and Applied Pharmacology, 1988
- Pharmacokinetic Interactions of Cimetidine 1987Clinical Pharmacokinetics, 1987
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986
- Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazoleBiochemical and Biophysical Research Communications, 1983
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978